The need for core outcome sets in renal cancer clinical effectiveness research

Steven MacLennan; Lisa M Wintner; Muhammad Imran Omar; Katharina Beyer; Ailbhe Lawlor; Sheela Tripathee; Saeed Dabestani; Lorenzo Marconi; Rachel H Giles; Rose Woodward; Mieke Van Hemelrijck; Axel Bex; Patricia Zondervan

doi:10.20517/2574-1225.2023.66

Mini-invasive Surgery ›› 2023, Vol. 7 ›› Issue (1) :23 DOI: 10.20517/2574-1225.2023.66

Editorial

The need for core outcome sets in renal cancer clinical effectiveness research

Author information +

¹Academic Urology Unit, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen AB25 2ZD, UK.

²University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck 6020, Austria.

³Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam 3015, the Netherlands.

⁴Translational Oncology and Urology Research (TOUR), King’s College London, London WC2R 2LS, UK.

⁵Department of Translational Medicine, Division of Urological Cancers, Lund University, Lund 22100, Sweden.

⁶Department of Urology, Kristianstad Central Hospital, Region Skane, Kristianstad 29133, Sweden.

⁷Department of Urology, Coimbra University Hospital, Coimbra 3000, Portugal.

⁸International Kidney Cancer Coalition, Duivendrecht 1115 HB, the Netherlands.

⁹UMC Utrecht Cancer Center, Utrecht 3541, the Netherlands.

¹⁰Action Kidney Cancer Charity, Manchester 06040, UK.

¹¹Department of Urology, The Netherlands Cancer Institute, Amsterdam 1013, the Netherlands.

¹²Specialist Centre for Kidney Cancer, Royal Free Hospital, London NW3 2QG, UK.

¹³University College London, Division of Surgery and Interventional Science, London NW3 2PS, UK.

¹⁴Department of Urology, Amsterdam University Medical Centers, Amsterdam 1013, the Netherlands.

Correspondence to: Dr. Steven MacLennan, Academic Urology Unit, Institute of Applied Health Sciences, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, UK. E-mail: steven.maclennan@abdn.ac.uk

Show less

History +

PDF

Keywords

Renal cancer / effectiveness research / core outcome set / systematic reviews / meta-analysis / clinical practice guideline

Cite this article

Download citation ▾

Steven MacLennan, Lisa M Wintner, Muhammad Imran Omar, Katharina Beyer, Ailbhe Lawlor, Sheela Tripathee, Saeed Dabestani, Lorenzo Marconi, Rachel H Giles, Rose Woodward, Mieke Van Hemelrijck, Axel Bex, Patricia Zondervan. The need for core outcome sets in renal cancer clinical effectiveness research. Mini-invasive Surgery, 2023, 7(1): 23 DOI:10.20517/2574-1225.2023.66

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Williamson PR,Bagley H.The COMET handbook: version 1.0.Trials2017;18:280 PMCID:PMC5499094

[2]	Guyatt GH,Schünemann HJ,Knottnerus A.GRADE guidelines: a new series of articles in the journal of clinical epidemiology.J Clin Epidemiol2011;64:380-2

[3]	Egger M,Altman DG. Systematic reviews in health care: meta-analysis in context. Second edition. London: BMJ Publishing Group; 2001. Available from: https://alraziuni.edu.ye/uploads/pdf/Systematic-Reviews-in-Health-Care-Meta-Analysis-in-Context_2001.pdf. [Last accessed on 26 Jun 2023]

[4]	Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from: https://training.cochrane.org/handbook#how-to-access. [Last accessed on 26 Jun 2023].

[5]	MacLennan S.The need for core outcome sets in urological cancer research.Transl Androl Urol2021;10:2832-5 PMCID:PMC8261447

[6]	Dwan K,Williamson PR.Reporting Bias GroupSystematic review of the empirical evidence of study publication bias and outcome reporting bias - an updated review.PLoS One2013;8:e66844 PMCID:PMC3702538

[7]	MacLennan S,Lapitan MC.UCAN Systematic Review Reference GroupEAU Renal Cancer Guideline PanelSystematic review of oncological outcomes following surgical management of localised renal cancer.Eur Urol2012;61:972-93

[8]	MacLennan S,Lapitan MC.UCAN Systematic Review Reference GroupEAU Renal Cancer Guideline PanelSystematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer.Eur Urol2012;62:1097-117

[9]	Rossi SH,Stewart GD.Quality of life outcomes in patients with localised renal cancer: a literature review.World J Urol2018;36:1961-72 PMCID:PMC6280814

[10]	York C. Systematic Reviews: CRD’s guidance for undertaking reviews in health care. Available from: https://www.york.ac.uk/media/crd/Systematic_Reviews.pdf. [Last accessed on 26 Jun 2023]

[11]	Beyer K,Wintner LM.A systematic review of heterogeneity in outcome definition and reporting in localised renal cancer.Eur Urol Open Sci2022;48:1-11 PMCID:PMC9791121

[12]	Kirkham JJ,Altman DG.Core outcome set-standardised protocol items: the COS-STAP statement.Trials2019;20:116 PMCID:PMC6371434

[13]	Kirkham JJ,Altman DG.Core outcome set-standards for development: the COS-STAD recommendations.PLoS Med2017;14:e1002447 PMCID:PMC5689835

[14]	Beaton D,Grosskleg S. The OMERACT handbook. Available from: https://omeract.org/wp-content/uploads/2021/12/OMERACT-Handbook-Chapter-Final-June_2_2021.pdf. [Last accessed on 26 Jun 2023]

[15]

Boers M,Felson D.World health organization and international league of associations for rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials.J Rheumatol Suppl1994;41:86-9Available from: https://pubmed.ncbi.nlm.nih.gov/7799394/. [Last accessed on 26 Jun 2023]

[16]	Kirkham JJ,Williamson PR.A methodological approach for assessing the uptake of core outcome sets using clinicaltrials.gov: findings from a review of randomised controlled trials of rheumatoid arthritis.BMJ2017;357:j2262 PMCID:PMC5434459

[17]	Kirkham JJ,Tugwell P,Williamson PR.Outcome measures in rheumatoid arthritis randomised trials over the last 50 years.Trials2013;14:324 PMCID:PMC3852710

[18]	MacLennan S,Beyer K. A protocol for the development of core outcome sets for effectiveness trials and clinical audits in renal cell cancer (R-COS). BJUI Compass 2023. Available from: https://bjui-journals.onlinelibrary.wiley.com/doi/10.1002/bco2.266. [Last accessed on 26 Jun 2023]